Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

UCB's nonsedating antihistamine approved in Germany

Jan. 16, 2001

Soluble inhibitors of protein kinase C designed at AstraZeneca for wide range of disorders

Jan. 12, 2001

Ivax joins forces with Harvard Medical School affiliate in CF research

Jan. 10, 2001

Symbicort combination asthma product approved in E.U.

Jan. 9, 2001

Efficacy and safety of JAK3 inhibitors in allergic asthma validated using WHI-P97

Jan. 9, 2001

Antiinflammatory compounds from Bayer act as PDE4 inhibitors

Jan. 8, 2001

Antiinflammatory and antiemetic effects of YM-976 evaluated in animal studies

Jan. 8, 2001

Use of (S)-oxybutynin for asthma claimed by Sepracor in recent patent

Jan. 4, 2001

Anticholinergic bronchodilator proves safe and effective as COPD maintenance therapy

Jan. 4, 2001

Novel antiinflammatory agents described by Bayer group

Jan. 2, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
In the clinic for June 12, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Beone, Bioinvent, Blossomhill, C4, Cellectis, Climb, Elixiron,...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...